HF-SRT vs. HS-WBRT in Treating Patients With Brain Oligometastases

Not yet recruitingOBSERVATIONAL
Enrollment

115

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Brain Oligometastases
Interventions
RADIATION

Hypofractionated Stereotactic Radiotherapy (HF-SRT)

The administered dose-fractionation schemes range between 30 and 35 Gy delivered within two weeks with a dose per fractionation ranging from 6 to 7 Gy.

RADIATION

Hippocampus-Sparing Whole-Brain Radiotherapy (HS-WBRT) plus memantine

"* The prescribed dose is 30 Gy delivered in 12 fractions for therapeutic or adjuvant WBRT.~* The prescription of memantine for finally twice-daily dosing will be prescribed as follows:~ * During the first 3 weeks concurrent with the delivery of hippocampus-sparing WBRT, 5-mg morning dose will be initially prescribed \[Week 1 -3\]~ * 5-mg twice a day in the following week \[Week 4\]~ * A morning dose of 10 mg and an evening dose of 5 mg in the following week \[Week 5\]~ * 10-mg twice a day for the subsequent weeks up to Week 24 \[Week 6 - 24\]"

Trial Locations (1)

333

Chang Gung Memorial Hospital, Taoyuan District

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT05807165 - HF-SRT vs. HS-WBRT in Treating Patients With Brain Oligometastases | Biotech Hunter | Biotech Hunter